2022
DOI: 10.1016/j.metop.2022.100173
|View full text |Cite
|
Sign up to set email alerts
|

The effects of gender-affirming hormone therapy on cardiovascular and skeletal health: A literature review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(16 citation statements)
references
References 51 publications
0
14
0
Order By: Relevance
“…However, whether such impairments occur through GAHT impacts on Zn uptake in transgender women is not yet known. Meanwhile, a review suggests a higher trabecular bone score and bone mineral density in the lumbar region in transgender women receiving GAHT [ 199 ].…”
Section: Resultsmentioning
confidence: 99%
“…However, whether such impairments occur through GAHT impacts on Zn uptake in transgender women is not yet known. Meanwhile, a review suggests a higher trabecular bone score and bone mineral density in the lumbar region in transgender women receiving GAHT [ 199 ].…”
Section: Resultsmentioning
confidence: 99%
“…Another respondent cited the effects of GTP on future fertility, as well as risks of blood clots, heart disease, and bone development. Studies investigating the effects of gender‐affirming hormone therapy did not find conclusive evidence of increased risk of heart attack, blood clots, or fracture (Chan Swe et al, 2022; Deutsch, 2016). Furthermore, transgender and gender‐diverse individuals have higher rates of other risk factors for cardiovascular disease, such as tobacco use and decreased physical activity, that are unrelated to hormone treatment (Defreyne et al, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…Other factors not accounted for in risk score algorithms may have a significant and disproportionate effect on dementia risk for TGD populations. For instance, increasing evidence suggests that gender‐affirming hormone therapies may increase cardiometabolic risk, 32 , 33 , 34 which could in turn contribute to a higher risk of dementia. Additionally, transgender and gender diverse individuals often face obstacles in accessing health care, which could compound these risks.…”
Section: Discussionmentioning
confidence: 99%